Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial.
Blake O LangleyJennifer Joan RyanDouglas HanesJohn PhippsEmily StackThomas O MetzJan Frederick StevensRyan D BradleyPublished in: Molecular nutrition & food research (2021)
Over an eight-week period, 24 mg daily xanthohumol was safe and well-tolerated by healthy adults.